Literature DB >> 17095349

Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia.

Elizabeth C Uong1, Jessica Henderson Boyd, Michael R DeBaun.   

Abstract

A prospective, infant cohort study of children with sickle cell anemia was evaluated to determine the relationship between daytime pulse oximeter measurements and the incidence of pain and acute chest episodes (ACS). A total of 130 children were evaluated. The Pearson correlation between SpO2 and pain and ACS episode rates were 0.00 (P = .97) and 0.10 (P = .27), respectively. Daytime SpO2 cannot independently predict the subsequent rate of pain and ACS episodes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17095349      PMCID： PMC1892315          DOI： 10.1016/j.jpeds.2006.06.038

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  11 in total

1.  Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease.

Authors:  Charles T Quinn; Naveed Ahmad
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

2.  Pulse oximetry in a cohort study of sickle cell disease.

Authors:  J Homi; L Levee; D Higgs; P Thomas; G Serjeant
Journal:  Clin Lab Haematol       Date:  1997-03

3.  The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

Authors:  S N Goodman; J A Berlin
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

4.  Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease.

Authors:  F J Kirkham; D K Hewes; M Prengler; A Wade; R Lane; J P Evans
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

5.  Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease.

Authors:  W R Rackoff; N Kunkel; J H Silber; T Asakura; K Ohene-Frempong
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

6.  Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.

Authors:  M Seakins; W N Gibbs; P F Milner; J F Bertles
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

7.  Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology.

Authors:  B N Yamaja Setty; Marie J Stuart; Carlton Dampier; Darcy Brodecki; Julian L Allen
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

8.  Sleep related upper airway obstruction and hypoxaemia in sickle cell disease.

Authors:  M P Samuels; V A Stebbens; S C Davies; E Picton-Jones; D P Southall
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

9.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

Authors:  O Castro; D J Brambilla; B Thorington; C A Reindorf; R B Scott; P Gillette; J C Vera; P S Levy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

10.  Nocturnal oxygen saturation and painful sickle cell crises in children.

Authors:  Darren R Hargrave; Angie Wade; Jane P M Evans; Deborah K M Hewes; Fenella J Kirkham
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113
View more
  8 in total

1.  Sleep disordered breathing does not predict acute severe pain episodes in children with sickle cell anemia.

Authors:  Shaina M Willen; Mark Rodeghier; Carol L Rosen; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

2.  Variability of pulse oximetry measurement over 1 year in children with sickle cell disease depends on initial oxygen saturation measurement.

Authors:  Jonathan E Mullin; Ben Cooper; Sinziana Seicean; Robert Strunk; Carol Rosen; Susan Redline; James Kemp; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2010-07-01       Impact factor: 3.167

3.  Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients.

Authors:  Andrew Campbell; Caterina P Minniti; Mehdi Nouraie; Manuel Arteta; Sohail Rana; Onyinye Onyekwere; Craig Sable; Gregory Ensing; Niti Dham; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2009-08-19       Impact factor: 6.998

4.  Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.

Authors:  Caterina P Minniti; Craig Sable; Andrew Campbell; Sohail Rana; Gregory Ensing; Niti Dham; Onyinye Onyekwere; Mehdi Nouraie; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

5.  Lower airway obstruction is associated with increased morbidity in children with sickle cell disease.

Authors:  Jessica H Boyd; Michael R DeBaun; Wayne J Morgan; Jingnan Mao; Robert C Strunk
Journal:  Pediatr Pulmonol       Date:  2009-03

6.  Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.

Authors:  Xiaomei Niu; Mehdi Nouraie; Andrew Campbell; Sohail Rana; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; N Scott Reading; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

7.  Nocturnal hypoxemia measured by polysomnogram is associated with acute chest syndrome in pediatric sickle cell disease.

Authors:  Anis Rabbani Nourani; A K M Fazlur Rahman; Brandi Pernell; Mary H Maddox; Lee Hilliard; Jeffrey Lebensburger; Ammar Saadoon Alishlash
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

8.  Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.

Authors:  Isabelle Halphen; Caroline Elie; Valentine Brousse; Muriel Le Bourgeois; Slimane Allali; Damien Bonnet; Mariane de Montalembert
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.